Skip to main content
Business

Billy Evans’ ‘Theranos 2.0’ startup has patents, investors, and a missing CTO—but no product

Billy Evans’ ‘Theranos 2.0’ startup has patents, investors, and a missing CTO—but no product

Feed excerpt — reported by Fortune

As You Can See Everything turns Billy Evans into the year’s most unlikely documentary villain, his Austin startup Haemanthus faces a simple question: What has it built?

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at Fortune →

Original Source

This article was syndicated from Fortune. All rights remain with the original publisher.